|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
|
US9752113B2
(en)
|
2012-03-15 |
2017-09-05 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10967298B2
(en)
|
2012-03-15 |
2021-04-06 |
Flodesign Sonics, Inc. |
Driver and control for variable impedence load
|
|
US9745548B2
(en)
|
2012-03-15 |
2017-08-29 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10689609B2
(en)
|
2012-03-15 |
2020-06-23 |
Flodesign Sonics, Inc. |
Acoustic bioreactor processes
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9950282B2
(en)
|
2012-03-15 |
2018-04-24 |
Flodesign Sonics, Inc. |
Electronic configuration and control for acoustic standing wave generation
|
|
US10322949B2
(en)
|
2012-03-15 |
2019-06-18 |
Flodesign Sonics, Inc. |
Transducer and reflector configurations for an acoustophoretic device
|
|
US10737953B2
(en)
|
2012-04-20 |
2020-08-11 |
Flodesign Sonics, Inc. |
Acoustophoretic method for use in bioreactors
|
|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
EP3783098A1
(en)
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
AU2014268364A1
(en)
|
2013-05-24 |
2015-12-10 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
US9745569B2
(en)
|
2013-09-13 |
2017-08-29 |
Flodesign Sonics, Inc. |
System for generating high concentration factors for low cell density suspensions
|
|
WO2015105955A1
(en)
|
2014-01-08 |
2015-07-16 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
EP3656864A1
(en)
|
2014-02-14 |
2020-05-27 |
Board of Regents, The University of Texas System |
Chimeric antigen receptors and methods of making
|
|
RU2763795C2
(ru)
|
2014-04-23 |
2022-01-11 |
Джуно Терапьютикс, Инк. |
Способы выделения, культивирования и генетической инженерии популяций клеток иммунной системы для адоптивной терапии
|
|
US9744483B2
(en)
|
2014-07-02 |
2017-08-29 |
Flodesign Sonics, Inc. |
Large scale acoustic separation device
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
FR3026744B1
(fr)
|
2014-10-06 |
2024-04-19 |
Hopitaux Paris Assist Publique |
Methode de generation de progeniteurs de cellules t
|
|
CA2964783C
(en)
|
2014-11-05 |
2024-01-23 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
EP4400516A1
(en)
|
2014-12-15 |
2024-07-17 |
The Regents of the University of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
|
EP3804741A3
(en)
|
2015-02-24 |
2021-07-14 |
Board of Regents, The University of Texas System |
Selection methods for genetically-modified t cells
|
|
KR102615825B1
(ko)
|
2015-03-11 |
2023-12-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
전위효소 폴리펩타이드 및 이의 용도
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11021699B2
(en)
|
2015-04-29 |
2021-06-01 |
FioDesign Sonics, Inc. |
Separation using angled acoustic waves
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
GB201507368D0
(en)
*
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
EP3328994A4
(en)
|
2015-07-31 |
2019-04-17 |
Memorial Sloan-Kettering Cancer Center |
CD56-Faced Antigen-Binding Proteins and Uses Thereof
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
US10633445B2
(en)
|
2015-09-15 |
2020-04-28 |
Board Of Regents The University Of Texas System |
T-cell receptor (TCR)-binding antibodies and uses thereof
|
|
US11059879B2
(en)
|
2015-10-27 |
2021-07-13 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
EP4074731A1
(en)
|
2015-11-04 |
2022-10-19 |
City of Hope |
Chimeric antigen receptors targeting her2
|
|
CA3004738A1
(en)
*
|
2015-11-09 |
2017-05-18 |
Aperisys, Inc. |
Modified immune cells and uses thereof
|
|
EP3407919A4
(en)
*
|
2016-01-28 |
2019-09-04 |
The Regents of the University of California |
METHOD FOR THE SELECTIVE EXPANSION AND ENRICHMENT OF CELLS TRANSDUCED WITH CHIMERIC ANTIGEN RECEPTORS AND TREATMENT OF HIV INFECTION
|
|
ES2879700T3
(es)
*
|
2016-02-05 |
2021-11-22 |
Hope City |
Administración de células T genomanipuladas para el tratamiento de cánceres en el sistema nervioso central
|
|
JP7282521B2
(ja)
|
2016-04-08 |
2023-05-29 |
パーデュー・リサーチ・ファウンデイション |
Ｃａｒ ｔ細胞療法のための方法および組成物
|
|
WO2017184968A1
(en)
*
|
2016-04-22 |
2017-10-26 |
Kura Oncology, Inc. |
Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
|
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
KR20250084978A
(ko)
*
|
2016-06-06 |
2025-06-11 |
시티 오브 호프 |
Baff-r 표적 키메라 항원 수용체-변형된 t 세포 및 그 용도
|
|
US20200208111A1
(en)
*
|
2016-06-09 |
2020-07-02 |
Branden S. Moriarity |
Genome-edited nk cell and methods of making and using
|
|
CN107523547A
(zh)
*
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抑制性抗体的car‑t细胞及其用途
|
|
US11583555B2
(en)
|
2016-06-24 |
2023-02-21 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Genetic re-engineering of immune cells to improve metabolic fitness for immunotherapy
|
|
CN107663240B
(zh)
|
2016-07-29 |
2021-01-12 |
中国人民解放军第四军医大学 |
高度糖基化cea特异性结合的单链抗体及其在检测和治疗上的应用
|
|
CA3034691A1
(en)
|
2016-08-30 |
2018-03-08 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use for treating viral and other infections
|
|
CA3041517A1
(en)
|
2016-10-19 |
2018-04-26 |
Flodesign Sonics, Inc. |
Affinity cell extraction by acoustics
|
|
WO2018124766A2
(ko)
|
2016-12-28 |
2018-07-05 |
주식회사 녹십자랩셀 |
키메라 항원 수용체 및 이를 발현하는 자연 살해 세포
|
|
IL268641B2
(en)
|
2017-02-13 |
2024-10-01 |
Assist Publique Hopitaux Paris Aphp |
Method for generating t cells progenitors
|
|
JP7178355B2
(ja)
|
2017-02-28 |
2022-11-25 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための組成物および方法
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
MX2019013514A
(es)
|
2017-05-12 |
2020-01-20 |
Crispr Therapeutics Ag |
Materiales y metodos para modificar celulas por ingenieria genetica y usos de los mismos en inmunooncologia.
|
|
CN107099603A
(zh)
*
|
2017-05-31 |
2017-08-29 |
成都克里斯博生物科技有限公司 |
肿瘤免疫t细胞检测试剂盒和检测方法
|
|
GB201709203D0
(en)
*
|
2017-06-09 |
2017-07-26 |
Autolus Ltd |
Antigen-binding domain
|
|
JP7210534B2
(ja)
|
2017-07-12 |
2023-01-23 |
ザ・ボード・オブ・トラスティーズ・オブ・ザ・リーランド・スタンフォード・ジュニア・ユニバーシティ |
Ｈ３ｋ２７ｍ変異を有するがんの処置のための組成物および方法
|
|
CN111432823A
(zh)
*
|
2017-07-25 |
2020-07-17 |
得克萨斯大学体系董事会 |
增强的嵌合抗原受体及其用途
|
|
TWI676483B
(zh)
*
|
2017-08-06 |
2019-11-11 |
強普生技股份有限公司 |
醫藥套組及其用途
|
|
CN107287165A
(zh)
*
|
2017-08-23 |
2017-10-24 |
湖南开启时代生物科技有限责任公司 |
一种car‑t细胞的制备方法
|
|
CN109468278A
(zh)
*
|
2017-09-08 |
2019-03-15 |
科济生物医药（上海）有限公司 |
基因工程化的t细胞及应用
|
|
EA202090757A1
(ru)
*
|
2017-09-29 |
2020-08-21 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
T-КЛЕТОЧНЫЕ РЕЦЕПТОРЫ, РАСПОЗНАЮЩИЕ МУТАНТНЫЙ p53
|
|
CN107488738B
(zh)
*
|
2017-10-12 |
2020-04-28 |
中国医学科学院肿瘤医院 |
一种预测乳腺癌对曲妥珠单抗联合化疗治疗敏感性的生物标志物
|
|
KR20200085780A
(ko)
|
2017-11-07 |
2020-07-15 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
암의 치료에서 car-t 또는 car-nk 세포를 사용한 lilrb4 표적화
|
|
US12116417B2
(en)
|
2017-11-14 |
2024-10-15 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
JP7517983B2
(ja)
*
|
2017-11-20 |
2024-07-17 |
ユリウス－マクシミリアン－ウニヴェルシテート・ヴュルツブルク |
非常に低レベルのｃｄ１９を発現する骨髄腫細胞を除去するｃｄ１９ｃａｒｔ細胞
|
|
CU24558B1
(es)
*
|
2017-11-28 |
2021-12-08 |
Ct Inmunologia Molecular |
Anticuerpos monoclonales que reconocen al receptor del factor de crecimiento epidérmico y sus fragmentos derivados
|
|
CN108070033A
(zh)
*
|
2017-12-12 |
2018-05-25 |
武汉波睿达生物科技有限公司 |
一种3bnc-car分子的构建及其在杀灭hiv-1感染细胞中的应用
|
|
WO2019118921A1
(en)
|
2017-12-14 |
2019-06-20 |
Flodesign Sonics, Inc. |
Acoustic transducer drive and controller
|
|
US11400117B2
(en)
|
2017-12-15 |
2022-08-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for inhibiting T cell exhaustion
|
|
WO2019119822A1
(en)
|
2017-12-23 |
2019-06-27 |
Uwell Biopharma Inc. |
Pharmaceutical chimeric receptor composition and method thereof
|
|
US12491153B2
(en)
|
2018-01-03 |
2025-12-09 |
Qu Biologics Inc. |
Innate targeting of adoptive cellular therapies
|
|
US11965191B2
(en)
|
2018-01-18 |
2024-04-23 |
California Institute Of Technology |
Programmable protein circuits in living cells
|
|
JP7549303B2
(ja)
*
|
2018-01-22 |
2024-09-11 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞の使用方法
|
|
WO2019147604A2
(en)
*
|
2018-01-23 |
2019-08-01 |
Vanderbilt University |
Self-antigen specific t-cells as vacines for augmenting engraftment and stability of autologous transfer
|
|
SG11202007426XA
(en)
|
2018-02-06 |
2020-09-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
CN112105382A
(zh)
|
2018-02-23 |
2020-12-18 |
恩多塞特公司 |
用于car t细胞疗法的顺序方法
|
|
EP3762422A1
(en)
*
|
2018-03-08 |
2021-01-13 |
Rubius Therapeutics, Inc. |
Therapeutic cell systems and methods for treating cancer and infectious diseases
|
|
US20190247437A1
(en)
*
|
2018-04-19 |
2019-08-15 |
APDN (B.V.I.), Inc. |
Engineered lymphocyte compositions, methods and systems
|
|
US12227763B2
(en)
|
2018-05-11 |
2025-02-18 |
Crispr Therapeutics Ag |
Methods and compositions for treating cancer
|
|
WO2020014285A2
(en)
|
2018-07-09 |
2020-01-16 |
Intrexon Corporation |
Fusion constructs and methods of using thereof
|
|
KR20210042125A
(ko)
*
|
2018-08-07 |
2021-04-16 |
퍼듀 리서치 파운데이션 |
Car t 세포의 회생
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
EP3844180A4
(en)
|
2018-08-31 |
2022-07-20 |
California Institute of Technology |
Synthetic protein circuits detecting signal transducer activity
|
|
AU2019336229A1
(en)
*
|
2018-09-07 |
2021-03-18 |
Sotio, LLC |
Chimeric receptor polypeptides in combination with trans metabolism molecules modulating intracellular lactate concentrations and therapeutic uses thereof
|
|
CN113164576A
(zh)
*
|
2018-10-05 |
2021-07-23 |
圣安娜儿童癌症研究中心 |
嵌合抗原受体(car)组
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
US12590148B2
(en)
|
2018-11-26 |
2026-03-31 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
WO2020146627A1
(en)
*
|
2019-01-10 |
2020-07-16 |
California Institute Of Technology |
A synthetic system for tunable thresholding of protein signals
|
|
KR20210119468A
(ko)
|
2019-01-25 |
2021-10-05 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
돌연변이체 ras를 표적화하기 위한 조성물 및 방법
|
|
WO2020163682A1
(en)
*
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas System |
Glucuronoxylomannan (gxm) receptor chimeric antigen receptors and use thereof
|
|
US20220125836A1
(en)
*
|
2019-02-08 |
2022-04-28 |
Biontech Cell & Gene Therapies Gmbh |
Treatment involving car-engineered t cells and cytokines
|
|
EP3924467A1
(en)
|
2019-02-15 |
2021-12-22 |
Editas Medicine, Inc. |
Modified natural killer (nk) cells for immunotherapy
|
|
KR20210129125A
(ko)
|
2019-02-20 |
2021-10-27 |
시티 오브 호프 |
Baff-r/cd19 표적화된 키메라 항원 수용체-변형된 t 세포 및 그의 용도
|
|
AU2020232691B2
(en)
|
2019-03-05 |
2023-06-29 |
Nkarta, Inc. |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
US20220249558A1
(en)
|
2019-04-30 |
2022-08-11 |
Crispr Therapeutics Ag |
Allogeneic cell therapy of b cell malignancies using genetically engineered t cells targeting cd19
|
|
MX2021015125A
(es)
*
|
2019-06-07 |
2022-04-06 |
Juno Therapeutics Inc |
Cultivo automatizado de celulas t.
|
|
AU2020286471B2
(en)
*
|
2019-06-07 |
2025-07-31 |
The Trustees Of The University Of Pennsylvania |
Dual CAR expressing T cells individually linked to CD28 and 4-1BB
|
|
CA3150224A1
(en)
|
2019-09-10 |
2021-03-18 |
Obsidian Therapeutics, Inc. |
Ca2 compositions and methods for tunable regulation
|
|
KR20220095228A
(ko)
*
|
2019-11-06 |
2022-07-06 |
베이롤 칼리지 오브 메드신 |
암의 t 세포 치료를 위한 세포독성 효과기 기억 t 세포를 생산하는 방법
|
|
CN115003386A
(zh)
*
|
2019-11-27 |
2022-09-02 |
宾夕法尼亚大学董事会 |
产生抗cd3 scfv和细胞因子的人工抗原呈递细胞
|
|
EP4073103A1
(en)
*
|
2019-12-11 |
2022-10-19 |
A2 Biotherapeutics, Inc. |
Lilrb1-based chimeric antigen receptor
|
|
AU2021217003A1
(en)
|
2020-02-04 |
2022-09-15 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Anti-dinitrophenol chimeric antigen receptors
|
|
CN115427440A
(zh)
*
|
2020-02-25 |
2022-12-02 |
圭尔医疗有限公司 |
用于工程化细胞的嵌合受体
|
|
CN111253493B
(zh)
*
|
2020-03-05 |
2021-03-23 |
武汉科技大学 |
一种靶向hiv病毒囊膜双位点的嵌合抗原受体及其表达载体和应用
|
|
US12264190B2
(en)
*
|
2020-04-24 |
2025-04-01 |
Astrazeneca Ab |
Compositions and methods of treating cancer with chimeric antigen receptors
|
|
CN113913459A
(zh)
*
|
2020-07-09 |
2022-01-11 |
杭州优凯瑞医药科技有限公司 |
一种应用非病毒方法制备高纯度嵌合抗原受体修饰的t细胞的方法及其应用
|
|
EP4178680A4
(en)
|
2020-07-10 |
2024-07-31 |
Precigen, Inc. |
FUSION CONSTRUCTS AND THEIR METHODS OF USE
|
|
KR102605723B1
(ko)
*
|
2020-11-11 |
2023-11-24 |
한국과학기술원 |
키메라 항원 수용체를 위한 타깃 항원 발굴 방법 및 분석 장치
|
|
CN114716548B
(zh)
*
|
2021-01-05 |
2024-11-05 |
(株)爱恩德生物 |
抗-fgfr3抗体及其用途
|
|
US20240327889A1
(en)
*
|
2021-04-05 |
2024-10-03 |
Victor TETS |
Regulation of cells and organisms
|
|
CA3216024A1
(en)
*
|
2021-04-08 |
2022-10-13 |
Artiva Biotherapeutics, Inc. |
Chimeric antigen receptor comprising an anti-her2 antibody or antigen-binding fragment thereof and natural killer cells comprising the same
|
|
AU2022299551A1
(en)
|
2021-06-23 |
2024-01-18 |
Editas Medicine, Inc. |
Engineered cells for therapy
|
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
|
EP4380966A2
(en)
|
2021-08-03 |
2024-06-12 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
|
WO2023021494A1
(en)
*
|
2021-08-20 |
2023-02-23 |
Rudd Christopher E |
Compositions and methods for anti-virus chimeric antigen receptor
|
|
CA3247010A1
(en)
*
|
2022-04-08 |
2023-10-12 |
Ono Pharmaceutical Co., Ltd. |
CHIMERIC ANTIGEN RECEPTOR FOR TUMOR TARGETING
|
|
EP4504914A4
(en)
|
2022-04-08 |
2026-04-29 |
Fate Therapeutics Inc |
Cells having solid tumor targeting backbone and use thereof
|
|
CN115873803B
(zh)
*
|
2022-11-28 |
2025-06-17 |
上海恩凯细胞技术有限公司 |
提高nk细胞存活和抗肿瘤活性的方法及应用
|
|
US20250152743A1
(en)
*
|
2023-11-13 |
2025-05-15 |
California Institute Of Technology |
Synpoptosis circuits for programmable cell death control
|
|
CN119080932A
(zh)
*
|
2024-09-02 |
2024-12-06 |
浙江大学 |
靶向表皮生长因子受体耐药性突变体的西妥昔单抗变体
|